(Q43950970)

28 November 2017

MicroRNA-148b expression is decreased in hepatocellular carcinoma and associated with prognosis (English)

1 reference

28 November 2017

1 reference

hepatocellular carcinoma

1 reference

Zhiyong Zhang

1

1 reference

28 November 2017

Wei Zheng

series ordinal

2

1 reference

28 November 2017

Jun Hai

series ordinal

3

1 reference

28 November 2017

8 May 2014

1 reference

28 November 2017

1 reference

28 November 2017

31

1 reference

28 November 2017

984

1 reference

28 November 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-014-0984-6

28 November 2017

0 references

cites work

Adult-specific functions of animal microRNAs

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

The functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Up-regulated MicroRNA-181a induces carcinogenesis in hepatitis B virus-related hepatocellular carcinoma by targeting E2F5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Role of miR-148a in hepatitis B associated hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Systematic review of efficacy and outcomes of salvage liver transplantation after primary hepatic resection for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Prevalence of hepatocellular carcinoma in Chinese Budd-Chiari syndrome patients: an extended systematic review using Chinese-language databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma - systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Short- and long-term outcomes after laparoscopic and open hepatectomy for hepatocellular carcinoma: a global systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Adjuvant therapy options following curative treatment of hepatocellular carcinoma: a systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Non-coding RNAs in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

MicroRNAs: critical regulators of development, cellular physiology and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0984-6

[Identification of metastasis-related microRNAs of hepatocellular carcinoma in hepatocellular carcinoma cell lines by quantitative real time PCR].

21 January 2018

1 reference

12 December 2020

MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma

1 reference

12 December 2020

A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer

1 reference

12 December 2020

Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease

1 reference

12 December 2020

10.1007/S12032-014-0984-6

Identifiers

DOI

1 reference

Dimensions Publication ID

28 November 2017

0 references

1 reference